Search Results

He has a degree and PhD in pharmacology from Queens' College, Cambridge and University College London , respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012, and was the recipient of the British Pharmacological Society Novartis Prize in 2017. Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience , ACS Pharmacology & Translational Science and Frontiers in Pharmacology.

The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors. He was the 2018 and 2021 recipient of the Young Investigator of the Year Awards from the British Pharmacological Society and International Cannabinoid Research Society (ICRS), respectively.

, a corresponding member of NC-IUPHAR, a member of the Faculty of 1000 and an elected Fellow of the British Pharmacological Society (BPS). Sexton’s awards include the ASCEPT Lecturer award, Endocrine Society (Australia) Senior Plenary award , Rand Medal (ASCEPT), Paxinos-Watson Award (Australian Neuroscience Society), Vane Medal (BPS), Gordon Hammes Lectureship Award (American Chemical Society) and the GSK Research Excellence award.

ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society. His research group uses a combination of pharmacological investigations and mathematical modeling to industry (GSK, Takada, and Firmenich) which have recently been enhanced through him being awarded a Royal Society

carried out his Ph.D. at King’s College London, supported by an AJ Clark Ph.D. studentship from the British Pharmacological Society. as Chief Scientific Officer, a contract research organization specializing in molecular and cellular pharmacology several pre-clinical drug discovery projects for both GPCR and non-GPCR targets, using its expertise in pharmacology

division) and an elected Fellow of the British Pharmacological Society (BPS). Sexton’s awards include the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Lecturer award, Endocrine Society of Australia Senior Plenary award, Rand Medal (ASCEPT), Paxinos-Watson Award (Australian Neuroscience Society), Vane Medal (BPS), Gordon Hammes Lectureship Award (American Chemical Society) and the GSK Research Excellence award.

I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group

Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Pharmacological Society, and in 2021 he was elected a Fellow of the Australian Academy of Science for In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Pharmacological Society, and in 2021 he was elected a Fellow of the Australian Academy of Science for In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Pharmacological Society, and in 2021 he was elected a Fellow of the Australian Academy of Science for In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

Committee Sponsors GPCR Retreat Program < Back to schedule Complex Allosteric Cannabinoid Receptor Pharmacology Devane Young Investigator Award from the International Cannabinoid Research Society (ICRS). Robert and his lab have been interested in the molecular pharmacology of cannabinoids for nearly 10 years

Gunnar Schulte Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology and Signaling at the Department of Physiology and Pharmacology. Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and a member of the editorial board/editorial advisory board of Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological Chemistry.

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics Khaled Abdelrahman on the web University of British Columbia Twitter PubMed Google Scholar Dr.

Applying Pharmacology to Drug Discovery Dr.

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

Home → Flash News → master gpcr pharmacologic models before its too late Published on July 11, 2025 Category Terry’s Corner breaks down the 4 pharmacologic models that separate forecasting from guessing. Dr. utm_content=bufferd9b30&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer #GPCR #Pharmacology Breakthroughs this week: Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma 5 days ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

Principles of Pharmacology in Drug Discovery I Dr.

Advanced data analysis for GPCR pharmacology Dr.

Principles of Pharmacology in Drug Discovery II Dr.

Home → Flash News → Unlock your pharmacology potential with Terry’s Corner. No fluff. Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug Early access begins July 1 → https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery # Apply pharmacology to selectivity, ADME, early safety, and smarter decision-making. 🟢 Already a drug Early access begins July 1 → https://www.terrykenakin.com #pharmacology #GPCRscience #drugdiscovery #

research—it’s a great way to stay motivated and inspired 🚀 Don’t miss this insightful conversation on GPCRs, pharmacology ✅ https://buff.ly/FTB69y9 #GPCR #DrGPCR #SciencePodcast #Pharmacology #CancerResearch Published on April ✅ https://buff.ly/FTB69y9 #GPCR #DrGPCR #SciencePodcast #Pharmacology #CancerResearch Recent Articles Breakthroughs this week: Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma 5 days ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

Principles of Pharmacology in Drug Discovery I Techniques for Effective Lead Optimization of Candidate still are the most prolific and fertile therapeutic drug targets; this course describes the essential pharmacologic In general, registrants will receive a comprehensive understanding of the unique science of pharmacology Registrants will learn: Essentials of measuring pharmacologic activity of ligands (affinity, efficacy Also super-valuable for those of us learning how to teach pharmacology Anonymous What would you like

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and

Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management on-demand learning to fit your schedule 🚀 Elevate your expertise today: Start learning now #GPCR #Pharmacology Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management on-demand learning to fit your schedule 🚀 Elevate your expertise today: Start learning now #GPCR #Pharmacology

Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones by the attribution of many awards and distinctions including his election as a fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics Maddi is currently a second year Ph.D. student in the Molecular Pharmacology and Therapeutics (MPaT)

Terry Kenakin will soon start the course Principles of Pharmacology II - Advanced Methods for the Optimization Terry Kenakin will soon start the course Principles of Pharmacology II - Advanced Methods for the Optimization

Home → Flash News → Exploring the combination of molecular simulation, pharmacological assays, and NMR Published on December 10, 2024 Category GPCR Weekly News Exploring the combination of molecular simulation, pharmacological Breakthroughs this week: Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma 5 days ago Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Recognizing, predicting, and leveraging these interactions is the essence of enzyme inhibition pharmacology—the